VEGFA and cancer: AKT, this pivotal protein, is documented to be highly hyperactivated in various cancer types [34,38], which increases VEGF secretion and other growth factors creating a feedback loop that aids in developing cancer resistance to many antiangiogenic therapies [39,40].